BIIB · US market

Biogen Inc

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$32.90bnFinancials dated 31 March 2026Price dated 1 October 2026

Core valuation

Trailing P/E23.98×
Latest-quarter run-rate P/E25.74×
Trailing P/S3.31×
Latest-quarter run-rate P/S3.32×

Calculation inputs

Trailing earnings
US$1.37bn
Latest-quarter run-rate earnings
US$1.28bn
Latest fiscal-year earnings
US$1.29bn
Trailing revenue
US$9.94bn
Latest-quarter run-rate revenue
US$9.91bn
Latest fiscal-year revenue
US$9.89bn

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

  • IBBQ · Invesco Nasdaq Biotechnology ETF5.05% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • PBE · Invesco Biotechnology & Genome ETF5.05% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • IBRN · iShares Neuroscience and Healthcare ETF4.12% weight · Holdings dated 21 August 2026
  • FTXH · First Trust Nasdaq Pharmaceuticals ETF3.84% weight · Holdings dated 30 June 2026
  • BBH · VanEck Biotech ETF3.63% weight · Holdings dated 30 June 2026
  • BMED · iShares Health Innovation Active ETF3.37% weight · Holdings dated 21 August 2026
  • FBT · First Trust NYSE Arca Biotechnology Index Fund3.37% weight · Holdings dated 30 June 2026
  • PJP · Invesco Pharmaceuticals ETF2.85% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • POSKX · PRIMECAP Odyssey Stock Fund2.27% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • FXH · First Trust Health Care AlphaDEX Fund2.23% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 31 March 2026. Informational research, not investment advice.